beLean.net

11/12/2021

After more than 15 years and more than 80 projects, we are proud to be on the splotlight. Thanks for all the trust we have received/… from our customers/…

08/12/2021

𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐞𝐯𝐞𝐫 𝐭𝐡𝐨𝐮𝐠𝐡𝐭 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐰𝐞𝐥𝐥-𝐛𝐞𝐢𝐧𝐠 𝐨𝐟 𝐲𝐨𝐮𝐫 𝐞𝐦𝐩𝐥𝐨𝐲𝐞𝐞𝐬?

At beLean.net this is a crucial aspect and it is now more than ever important to invest in the well-being and health of our team.

This is why we have chosen to work with Conscious Motions, a young start-up whose focus is to help companies implement to improve , and at work. They offer simple, effective and human solutions that promote employee happiness and productivity.

𝐖𝐡𝐲 𝐢𝐬 𝐭𝐡𝐢𝐬 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭?

Implementing Corporate Wellness Days in the company allows the employees to:

- improve well-being 🙏
- stress management 💆
- connect and enjoy a team-building 🤜 🤛
- reduce absence due to sickness 🤒
- improve sleep 💤

𝐁𝐮𝐭 𝐰𝐡𝐚𝐭 𝐰𝐨𝐮𝐥𝐝 𝐛𝐞 𝐭𝐡𝐞 𝐩𝐮𝐫𝐩𝐨𝐬𝐞 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐲?

Yes, it's a little less working hours, but in the long run, the results are really worth it! Some of them are:

- strengthening team 👥
- increase in 🚀
- and 🕺
- increased and 😁
- increased and ✅

𝐚𝐧𝐝 𝐭𝐡𝐚𝐭, 𝐚𝐬 𝐚 𝐂𝐄𝐎, 𝐢𝐬 𝐩𝐫𝐢𝐜𝐞𝐥𝐞𝐬𝐬!

Let Conscious Motions help you implement your next onsite Corporate Wellness Days in order to improve your employees mood, well-being and performances like they did for us 💪.

Want to find out more about Conscious Motions and how they can also help you and your team's well-being? Don’t hesitate to contact Benjamin Hébert.

𝐁𝐨𝐨𝐤 𝐚 𝐦𝐞𝐞𝐭𝐢𝐧𝐠 👉 https://lnkd.in/gz3PMDra
𝐌𝐨𝐫𝐞 𝐢𝐧𝐟𝐨 👉 https://lnkd.in/gjWwzKHw

01/12/2021

📣 We are hiring! We are looking for our next Finance Consultant to join our team.

Ready for the adventure? ⛰️

Check out our and apply here 👉 https://lnkd.in/gVNH8Utm 📨

BELEAN.NET: We are part-time CFO for start-ups and scale-ups in biotech and digital. We support

09/11/2021

OncoDNA and SOPHiA GENETICS - the two European players in profiling tests and data interpretation for the treatment of advanced cancers - are partnering up to create an all-in-one platform that automates the entire tumor profiling process.

Discover how 👉 https://lnkd.in/gxnC96-p

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐛𝐨𝐨𝐬𝐭 𝐲𝐨𝐮𝐫 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐨𝐫 𝐦𝐞𝐝𝐭𝐞𝐜𝐡 𝐩𝐫𝐨𝐣𝐞𝐜𝐭? 𝐁𝐨𝐨𝐤 𝐚 𝐦𝐞𝐞𝐭𝐢𝐧𝐠 𝐭𝐨 𝐛𝐞𝐧𝐞𝐟𝐢𝐭 𝐟𝐫𝐨𝐦 𝐨𝐮𝐫 𝐩𝐚𝐫𝐭-𝐭𝐢𝐦𝐞 𝐂𝐅𝐎 𝐬𝐞𝐫𝐯𝐢𝐜𝐞𝐬 👉 https://lnkd.in/gVvFpYu 📅

OncoDNA, the genomic and theranostic company specializing in precision medicine for the treatment of cancer

20/10/2021

Last week we took part in the , two days of very inspiring panel discussions 🗣️ about brain innovations 🚀, their challenges 💪 and their importance for the future 🧠.

What a blast to finally meet all the brain innovators in person after our virtual launch in October 2020 and our digital in January 2021! 🤩

𝐘𝐨𝐮 𝐜𝐨𝐮𝐥𝐝𝐧'𝐭 𝐦𝐞𝐞𝐭 𝐮𝐬 𝐚𝐧𝐝 𝐲𝐨𝐮 𝐧𝐞𝐞𝐝 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐭𝐨 𝐛𝐨𝐨𝐬𝐭 𝐲𝐨𝐮𝐫 𝐩𝐫𝐨𝐣𝐞𝐜𝐭 𝐢𝐧 𝐛𝐫𝐚𝐢𝐧 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧? 𝐁𝐨𝐨𝐤 𝐚 𝐦𝐞𝐞𝐭𝐢𝐧𝐠 👉 https://lnkd.in/gVvFpYu 📆

Developing treatments will significantly help and improve the lives of those living with brain disorders. We all know how extremely challenging this can be and this is why we need to work together!
Building the brain innovation ecosystem of tomorrow, creating synergies and showcase ongoing initiatives is the key!

Thank you for being !

With European Brain Council, Ebrains_eu, icompanion (from icometrix), PIPRA AG, Living With MS during COVID-19, VIB, Women's Brain Project, Walk With Path, Neurorhb - Servicio Neurorrehabilitación, Univerzitet u Beogradu, Paracelsus Medizinische Privatuniversität (PMU), Università degli Studi di Milano, (from Lundbeckfonden), , , , Neeuro, , KUKA, kop science + consulting, King's College London, International Headache Society, - Institut de Neurosciences des Systèmes, GAMIAN-Europe, Federation of European Neuroscience Societies (FENS), , epihunter, Emory Center for Ethics, European Federation of Neurological Associations, European Academy of Neurology, Dana Foundation, Byteflies, , - European Brain Research Area, , Sanofi Ventures, ...

11/10/2021

We are only 24h away from ! 🤩

Any questions on , dilutive and non-dilutive ? Want to boost your project in ? Please visit us at the Village Area from the upcoming , we will be pleased to advise you.

📅 12-13 October 2021
📍 Area 42, Brussels

With European Brain Council, Ebrains_eu, icompanion (from icometrix), PIPRA AG, Living With MS during COVID-19, VIB, Women's Brain Project, Walk With Path, Neurorhb - Servicio Neurorrehabilitación, Univerzitet u Beogradu, Paracelsus Medizinische Privatuniversität (PMU), Università degli Studi di Milano, (from Lundbeckfonden), , , , Neeuro, , KUKA, kop science + consulting, King's College London, International Headache Society, - Institut de Neurosciences des Systèmes, GAMIAN-Europe, Federation of European Neuroscience Societies (FENS), , epihunter, Emory Center for Ethics, European Federation of Neurological Associations, European Academy of Neurology, Dana Foundation, Byteflies, , - European Brain Research Area, , Ventures, ...

05/10/2021

It took 15 years for Belgium 🇧🇪 to build a well-developed in its southern region - Wallonia - thanks to a highly-skilled workforce and support from public authorities all combined to foster and boost and 🧬. Today, these SMEs are bought out, go public, produce for foreign groups, … 𝘮𝘢𝘬𝘪𝘯𝘨 𝘞𝘢𝘭𝘭𝘰𝘯𝘪𝘢 𝘵𝘩𝘦 𝘣𝘪𝘰𝘱𝘩𝘢𝘳𝘮𝘢𝘤𝘦𝘶𝘵𝘪𝘤𝘢𝘭 𝘷𝘢𝘭𝘭𝘦𝘺 𝘰𝘧 𝘌𝘶𝘳𝘰𝘱𝘦.

Discover the reasons of this success 👉 https://belean.net/2021/09/30/the-success-of-wallonia-the-biopharmaceutical-valley-of-europe/

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐛𝐨𝐨𝐬𝐭 𝐲𝐨𝐮𝐫 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐨𝐫 𝐦𝐞𝐝𝐭𝐞𝐜𝐡 𝐩𝐫𝐨𝐣𝐞𝐜𝐭? 𝐁𝐨𝐨𝐤 𝐚 𝐦𝐞𝐞𝐭𝐢𝐧𝐠 𝐭𝐨 𝐛𝐞𝐧𝐞𝐟𝐢𝐭 𝐟𝐫𝐨𝐦 𝐨𝐮𝐫 𝐩𝐚𝐫𝐭-𝐭𝐢𝐦𝐞 𝐂𝐅𝐎 𝐬𝐞𝐫𝐯𝐢𝐜𝐞𝐬 👉 https://lnkd.in/gVvFpYu 📅



With GSK, UCB, Takeda Oncology, Eurogentec (Kaneka Belgium NV), Bone Therapeutics, , Promethera Therapeutics, , OncoDNA, , , Epitopoietic Research Corporation, (Catalent Gosselies), (Catalent Pharma Solutions LLC), (Thermo Fisher Scientific), , CluePoints, Nyxoah, , Cefaly, IBA Proton Therapy, , (Telix Pharmaceuticals Limited), , Diagenode, a Hologic company, , , (CellCarta), Mithra, (Astellas Pharma US), EyeD Pharma, (spin-out of Vésale Pharma), , Miracor Medical Systems, , , ...

It took 15 years for Belgium to build a well-developed ecosystem in its southern region - Wallonia - thanks to a highly-skilled workforce and support from public authorities all combined to foster and boost research and innovation. Today, these SMEs are bought out, go public, produce for foreign gro...

14/09/2021

📣 We're excited to announce that registration for the 🧠, taking place on 12-13 October in Brussels, is now open!

Register now 👉 www.braininnovationdays.eu

You can look forward to a programme filled with policy-driven sessions, application-led breakout sessions & Agoras, face-to-face networking, real human interactions & inspiring Brain Talks.

Don't miss the chance to join the brain innovation community brought together in-person again!


co-organised by European Brain Council and beLean.net
in collaboration with Phrenos
sponsored by GW Pharmaceuticals, Tianqiao and Chrissy Chen Institute, Novartis, and Iconeus
in partnership with Broadreach Global and Imec.istart

02/08/2021

A first-round funding of 3M€ has been raised by , the spinout of Vésale Pharma which focuses on .

Discover how beLean.net was able to attract a first round of investors like Fondation Fournier-Majoie within a few weeks only 👉 https://lnkd.in/gm3fPcc

According to Guillaume de Viron, Vésale Bioscience CFO & beLean.net Partner: “𝘗𝘩𝘢𝘨𝘦 𝘵𝘩𝘦𝘳𝘢𝘱𝘺 𝘪𝘴 𝘪𝘯 𝘢 𝘱𝘢𝘳𝘵𝘪𝘤𝘶𝘭𝘢𝘳𝘭𝘺 𝘱𝘰𝘴𝘪𝘵𝘪𝘷𝘦 𝘧𝘭𝘶𝘹 𝘢𝘵 𝘵𝘩𝘦 𝘮𝘰𝘮𝘦𝘯𝘵. 𝘛𝘩𝘦 𝘌𝘶𝘳𝘰𝘱𝘦𝘢𝘯 𝘜𝘯𝘪𝘰𝘯 𝘪𝘴 𝘢𝘣𝘰𝘶𝘵 𝘵𝘰 𝘪𝘴𝘴𝘶𝘦 𝘯𝘦𝘸 𝘳𝘦𝘨𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘧𝘰𝘳 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵𝘴 𝘢𝘨𝘢𝘪𝘯𝘴𝘵 𝘳𝘦𝘴𝘪𝘴𝘵𝘢𝘯𝘵 𝘣𝘢𝘤𝘵𝘦𝘳𝘪𝘢. 𝘈𝘵 𝘱𝘳𝘦𝘴𝘦𝘯𝘵, 𝘵𝘩𝘦𝘳𝘦 𝘪𝘴 𝘯𝘰 𝘦𝘧𝘧𝘦𝘤𝘵𝘪𝘷𝘦 𝘢𝘭𝘵𝘦𝘳𝘯𝘢𝘵𝘪𝘷𝘦 𝘵𝘰 𝘱𝘩𝘢𝘨𝘦 𝘵𝘩𝘦𝘳𝘢𝘱𝘺. 𝘔𝘰𝘳𝘦𝘰𝘷𝘦𝘳, 𝘵𝘩𝘦 𝘯𝘶𝘮𝘣𝘦𝘳 𝘰𝘧 𝘤𝘰𝘮𝘱𝘢𝘯𝘪𝘦𝘴 𝘢𝘤𝘵𝘪𝘷𝘦 𝘪𝘯 𝘵𝘩𝘪𝘴 𝘮𝘢𝘳𝘬𝘦𝘵 𝘩𝘢𝘴 𝘢𝘭𝘮𝘰𝘴𝘵 𝘥𝘰𝘶𝘣𝘭𝘦𝘥 𝘪𝘯 𝘳𝘦𝘤𝘦𝘯𝘵 𝘮𝘰𝘯𝘵𝘩𝘴.” (freely translated from L'Echo, https://lnkd.in/giWgzq8)

𝐍𝐞𝐞𝐝 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐢𝐧 𝐲𝐨𝐮𝐫 𝐟𝐮𝐧𝐝𝐢𝐧𝐠 𝐭𝐨𝐨? 𝐁𝐨𝐨𝐤 𝐚 𝐦𝐞𝐞𝐭𝐢𝐧𝐠 👉 https://lnkd.in/gVvFpYu 📅

En préparation de son IPO, avancée à fin 2022, Vesale Biosciences récolte une première levée de fonds auprès d'investisseurs privés.

22/06/2021

“𝘛𝘩𝘦 𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘢𝘯𝘥 𝘋𝘦𝘷𝘦𝘭𝘰𝘱𝘮𝘦𝘯𝘵 𝘴𝘶𝘣𝘴𝘪𝘥𝘪𝘢𝘳𝘺 𝘰𝘧 𝘝𝘦𝘴𝘢𝘭𝘦 𝘗𝘩𝘢𝘳𝘮𝘢 𝘩𝘢𝘴 𝘫𝘶𝘴𝘵 𝘳𝘦𝘤𝘳𝘶𝘪𝘵𝘦𝘥 𝘢 𝘩𝘪𝘨𝘩-𝘲𝘶𝘢𝘭𝘪𝘵𝘺 𝘊𝘍𝘖, 𝘸𝘪𝘵𝘩 𝘶𝘯𝘱𝘢𝘳𝘢𝘭𝘭𝘦𝘭𝘦𝘥 𝘦𝘹𝘱𝘦𝘳𝘪𝘦𝘯𝘤𝘦. 𝘛𝘩𝘪𝘴 𝘪𝘴 𝘎𝘶𝘪𝘭𝘭𝘢𝘶𝘮𝘦 𝘥𝘦 𝘝𝘪𝘳𝘰𝘯.” headlines L.Post, the new pure player media in .

Discover how Guillaume de Viron, Partner at beLean.net, will contribute as to Vésale Pharma , 🦠 and accelerate its 🏦 thanks to his experience 👉 https://belean.net/2021/06/22/vesale-bioscience-calls-on-belean-net-to-prepare-and-accelerate-its-ipo/

Guillaume is the of the start-up , which develops and produces vaccines at low cost and has received millions of aid, notably from the Gatesfoundation and the European Investment Bank; he was also CFO of , another start-up in the sector for which he prepared the quotation on the and , before its for 285M€ by the American group Catalent Pharma Solutions LLC in 2020; he has also performed the same function in other and companies (OncoDNA, , KitoZyme, etc.).

𝐍𝐞𝐞𝐝 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐢𝐧 𝐲𝐨𝐮𝐫 𝐠𝐫𝐨𝐰𝐭𝐡 𝐭𝐨𝐨? 𝐁𝐨𝐨𝐤 𝐚 𝐦𝐞𝐞𝐭𝐢𝐧𝐠 👉 https://calendly.com/guillaume-belean 📅

Vésale Bioscience has hired Guillaume de Viron, Partner at beLean.net, as Chief Financial Officer in order to

17/06/2021

📣 SAVE THE DATE for the upcoming event, to be held IN PERSON on 12-13 October 2021 in Brussels under the overarching theme, “United for Brain Innovation".


The session will feature key opinion leaders and from the ever-growing brain innovation to create synergies and showcase the importance of brain innovation.


Stay tuned for more programme details coming soon 👉www.braininnovationdays.eu

Add to calendar 📅 https://belean.net/2021/06/17/brain-innovation-days-physical-event-save-the-date/





co-organised by European Brain Council and beLean.net

in collaboration with Phrenos

sponsored by Novartis, Tianqiao and Chrissy Chen Institute and

15/06/2021

A few months ago, raised €21M and opened its capital to its new American partner, Pfizer. 📈

Thanks to the development of the active technology to address autoimmune diseases, a licensing agreement has been signed with Pfizer, who have been collaborating together since 2017.

Discover how we supported Imcyse to raise €35M in a series B financing round in 2019 which prepared the ground for this future fundraising with Pfizer in 2021 👉 https://belean.net/2021/04/15/imcyse-signs-licensing-agreement-with-pfizer/

The Liège-based biotech company completes an ambitious fund-raising campaign and opens its capital to its new American partner.